An overview of the genes and biomarkers in Alzheimer's disease.

导出 LinkOut

翻译打印收藏纠错

作者： Hari Krishnan,Krishnamurthy ^[1] ; Vasanth,Jayaraman ^[2] ; Karthik,Krishna ^[3] ; Tianhao,Wang ^[4] ; Kang,Bei ^[5] ; Chithra,Changalath ^[6] ; John J,Rajasekaran ^[7]

作者单位： Vibrant Sciences LLC., San Carlos, CA, United States of America. Electronic address: hari@vibrantsci.com. ^[1] Vibrant Sciences LLC., San Carlos, CA, United States of America. Electronic address: vasanth.jayaraman@vibrantsci.com. ^[2] Vibrant Sciences LLC., San Carlos, CA, United States of America. Electronic address: karthik@vibrantsci.com. ^[3] Vibrant Sciences LLC., San Carlos, CA, United States of America. Electronic address: tianhao.wang@vibrantsci.com. ^[4] Vibrant Sciences LLC., San Carlos, CA, United States of America. Electronic address: kang@vibrantsci.com. ^[5] Vibrant America LLC., San Carlos, CA, United States of America. Electronic address: chithra.s@vitasoft-tech.com. ^[6] Vibrant Sciences LLC., San Carlos, CA, United States of America. Electronic address: jjrajasekaran@vibrantsci.com. ^[7]

关键词 Alzheimer’s disease Amyloid plaque Biomarker Neurofibrillary tangles Preclinical Preventive measures

主题词阿尔茨海默病(Alzheimer Disease);人类(Humans);疾病遗传易感性(Genetic Predisposition to Disease)

DOI 10.1016/j.arr.2024.102599

PMID 39612989

发布时间 2025-02-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交